The present invention relates to compounds and methods which may be useful as inhibitors of HIF pathway activity for the treatment or prevention of cancer and other hypoxia-mediated diseases.
University
University of Texas System
Assignee
Institute For Applied Cancer Science/The University of Texas MD Anderson Cancer …